comparemela.com

Latest Breaking News On - Niravs jhaveri - Page 1 : comparemela.com

Ocuphire Pharma, Inc. (NASDAQ:OCUP) CFO Acquires $21,000.00 in Stock

Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Free Report) CFO Nirav S. Jhaveri purchased 10,000 shares of the company’s stock in a transaction on Thursday, March 21st. The shares were purchased at an average price of $2.10 per share, with a total value of $21,000.00. Following the completion of the purchase, the chief financial officer now […]

Niravs-jhaveri
Ocuphire-pharma
Geode-capital-management
Nasdaq
Renaissance-technologies
Blackrock-inc
Prelude-capital-management
Ocuphire-pharma-company-profile
Alliance-global-partners
Shaughnessy-asset-management
Ocuphire-pharma-inc
Get-free-report

Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying - FTC Solar (NASDAQ:FTCI), Design Therapeutics (NASDAQ:DSGN)

The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Josephk-schachle
Ahmadr-chatila
Ocuphire-pharma
Niravs-jhaveri
Heathera-berger
Johnp-schmid
Ocuphire-pharma-inc
Solar-inc
Design-therapeutics-inc
Dow-jones
Ocuphire-pharma-does
Design-therapeutics

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.